tiprankstipranks
Trending News
More News >
Tscan Therapeutics, Inc. (TCRX)
NASDAQ:TCRX
US Market

Compare TScan Therapeutics (TCRX) vs. Competitors

Compare
312 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
TScan Therapeutics
$1.17
$68.10M
-54.37%
5 Buy
2 Hold
0 Sell
Moderate Buy
Zentalis Pharmaceuticals
$1.41
$253.60M
-1.68
32.70%
4 Buy
2 Hold
0 Sell
Moderate Buy
ALX Oncology Holdings
$1.33
$72.11M
-0.66
-16.35%
3 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.68
$206.15M
-2.98
-36.09%
4 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$20.00
$171.43M
-0.92
78.73%
3 Buy
0 Hold
0 Sell
Strong Buy
Instil Bio
$7.15
$48.76M
-0.63
-64.10%
0 Buy
2 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TCRX
TScan Therapeutics
1.20
-1.26
-51.22%
ZNTL
Zentalis Pharmaceuticals
3.51
1.12
46.86%
ALXO
ALX Oncology Holdings
1.33
-0.30
-18.40%
IKT
Inhibikase Therapeutics
1.70
-1.06
-38.41%
SRZN
Surrozen
20.00
8.15
68.78%
TIL
Instil Bio
7.19
-14.23
-66.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts